SSA
CORT icon

Schonfeld Strategic Advisors’s Corcept Therapeutics CORT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$11.4K – 2109
2025
Q1 		$11.4K Buy
+100
New +$6.09K ﹤0.01% 2118
2024
Q3 		– Sell
-11,346
Closed -$369K – 2095
2024
Q2 		$369K Buy
+11,346
New +$311K ﹤0.01% 1603
2022
Q4 		– Sell
-37,068
Closed -$950K – 2652
2022
Q3 		$950K Buy
+37,068
New +$992K 0.01% 1303
2020
Q2 		– Sell
-15,162
Closed -$180K – 1283
2020
Q1 		$180K Buy
+15,162
New +$188K 0.01% 928
2017
Q2 		– Sell
-100,005
Closed -$1.1M – 634
2017
Q1 		$1.1M Sell
100,005
-198,984
-67% -$1.75M 0.11% 242
2016
Q4 		$2.17M Buy
+298,989
New +$2.34M 0.28% 103

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return